Insmed Newsroom

Insmed Analyst Ratings

BenzingaAug 29 07:52 ET

H.C. Wainwright Maintains Insmed(INSM.US) With Buy Rating, Maintains Target Price $90

Moomoo NewsAug 29 06:31 ET

Insmed's Brensocatib Poised for Market Leadership: A Buy Rating Amidst Unthreatening Competition

TipRanksAug 29 06:30 ET

Buy Rating Affirmed for Insmed on Breakthrough Trials and Market Expansion Opportunities

TipRanksAug 13 10:09 ET

Insmed Analyst Ratings

BenzingaAug 12 07:34 ET

Truist Financial Reaffirms Their Buy Rating on Insmed (INSM)

TipRanksAug 12 07:32 ET

Brensocatib Poised for Market Success: A Buy Rating for Insmed Amid Positive KOL Sentiment and Limited Competition

TipRanksAug 12 06:37 ET

Insmed (INSM) Receives a Buy From Morgan Stanley

TipRanksAug 9 09:48 ET

Insmed Analyst Ratings

BenzingaAug 9 08:38 ET

Insmed's Promising Outlook: Buy Rating Backed by Arikayce Performance and Brenso Launch Potential

TipRanksAug 9 07:31 ET

Strong Arikayce Sales and Promising Clinical Advancements Bolster Buy Rating for Insmed

TipRanksAug 8 21:37 ET

Insmed Analyst Ratings

BenzingaJul 12 13:02 ET

Barclays Keeps Their Buy Rating on Insmed (INSM)

TipRanksJul 12 04:19 ET

Goldman Sachs Raises Price Target on Insmed to $102 From $74, Maintains Buy Rating

MT NewswiresJul 10 11:52 ET

Goldman Sachs Maintains Buy on Insmed, Raises Price Target to $102

BenzingaJul 10 11:27 ET

Insmed Analyst Ratings

BenzingaJul 9 12:24 ET

HC Wainwright Adjusts Price Target on Insmed to $90 From $70, Maintains Buy Rating

MT NewswiresJul 8 09:27 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: CureVac (CVAC), Insmed (INSM) and Quest Diagnostics (DGX)

TipRanksJul 8 04:43 ET

Insmed (INSM) Receives a Buy From Evercore ISI

TipRanksJul 8 04:34 ET

Insmed Analyst Ratings

BenzingaJul 5 09:22 ET